Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 in Japanese Patients With Severe Hypertension
NCT01646671Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in hypertension (HTN), sponsored by Novartis. Started Jul 2012; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01646671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01646671.